Table 5.
Variables associated with CG eCrCl <60 ml/min
| Variable | Cumulative proportion | OR (95% CI)a |
|---|---|---|
| of deviance explained, % | ||
| Age (per 10 years) | 20.6 | 3.67 (3.43, 3.92) |
| BMI (per 5 kg/cm2) | 24.6 | 0.57 (0.54, 0.61) |
| Urinary ACR (per doubling) | 25.5 | 1.11 (1.08, 1.14) |
| Race/ethnicity (ref. Caucasian) | 26.1 | |
| African | 1.06 (0.63, 1.79) | |
| Asian | 1.12 (0.84, 1.49) | |
| Hispanic | 3.20 (2.40, 4.25) | |
| Other | 1.11 (0.81, 1.52) | |
| Missing | 1.21 (1.03, 1.42) | |
| Duration of hypertension missing | 26.5 | 0.73 (0.65, 0.81) |
| Retinopathy | 26.8 | 1.46 (1.25, 1.70) |
| Sex (ref. female) | 27.0 | |
| Male | 0.79 (0.71, 0.88) | |
| Missing | 0.44 (0.26, 0.75) | |
| Duration of diabetes (per 5 years) | 27.1 | 1.08 (0.04, 1.13) |
| HbA1c missing | 27.2 | 1.24 (1.08, 1.42) |
| Hyperlipidemia | 27.2 | 1.12 (1.01, 1.25) |
| Diabetic foot | 27.3 | 1.26 (0.98, 1.60) |
| Region (ref. Europe) | 27.3 | |
| Africa | 0.84 (0.58, 1.19) | |
| Asia | 1.14 (0.84, 1.55) | |
| Central/South America | 0.78 (0.57, 1.06) | |
| North America | 0.82 (0.70, 0.96) | |
| Oceania | 1.00 (0.80, 1.26) | |
| Smoking history (ref. no) | 27.4 | 1.11 (0.98, 1.26) |
| Duration of hypertension (per 5 years) | 27.4 | 1.03 (0.99, 1.08) |
a Data are expressed as calculated effect. Data in bold are factors in which the 95% CI does not span 1.